8-K: GoHealth Reports Mixed Second Quarter Results with Revenue Decline but Improved Net Loss

GoHealth's second quarter results show a decrease in revenue and submissions, but an improvement in net loss compared to the same period last year.

Summary

• GoHealth announced its financial results for the second quarter of 2024, showing a net revenue of $105.9 million, which is a $36.9 million decrease compared to the $142.8 million reported in the same quarter of the previous year.
• The company experienced a net loss of $59.3 million, an improvement of $10.9 million compared to the $70.2 million net loss in the second quarter of 2023.
• Adjusted EBITDA for the quarter was negative $12.3 million, a decrease of $13.1 million compared to the positive $0.8 million in the prior year period.
• Submissions decreased by 6% to 152,394, driven by a decline in external agent submissions, although internal captive agent submissions increased.
• Trailing twelve months positive cash flow from operations was $53.8 million, a decrease of $32.1 million compared to $85.9 million in the prior year period.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant revenue decline and negative Adjusted EBITDA, despite some improvements in net loss and positive comments about future growth. The decrease in submissions is also a concern.

Positives

• The net loss improved by $10.9 million compared to the same quarter last year, indicating progress in controlling losses.
• Internal captive agent submissions increased year-over-year, showing strength in the company's internal sales channels.
• GoHealth is actively investing in AI and automation to improve operational efficiency and customer experience.
• The company is intensifying marketing efforts for the upcoming AEP, which could lead to increased submissions and revenue.
• GoHealth's proprietary Encompass workflow and PlanFit CheckUp process are highlighted as beneficial.

Negatives

• Net revenues decreased by $36.9 million compared to the same quarter last year, indicating a significant drop in sales.
• Total submissions decreased by 6%, driven by a decline in external agent submissions.
• Adjusted EBITDA decreased by $13.1 million, moving from positive to negative year-over-year.
• Trailing twelve months positive cash flow from operations decreased by $32.1 million compared to the prior year period.

Risks

• The company is experiencing a decline in revenue and submissions, which could impact future financial performance.
• The decrease in external agent submissions poses a risk to overall submission volume.
• The negative Adjusted EBITDA indicates challenges in profitability.
• The decrease in cash flow from operations could limit the company's ability to invest in growth initiatives.
• The company is subject to risks and uncertainties that could cause actual results to differ materially from forward-looking statements.

Future Outlook

GoHealth anticipates growth in submission volume, revenue, and Adjusted EBITDA for the remainder of 2024, with a focus on agency agreements to drive cash flow. They are confident in their performance expectations for 2024.

Management Comments

• Vijay Kotte, CEO of GoHealth, stated that the decline in net revenues was due to a 6% decrease in total Submissions, with internal captive agent growth offset by a decline in external agent submissions.
• Vijay Kotte also mentioned that they are pleased with the performance of their internal captive agents and that the results highlight the benefits of their proprietary Encompass workflow and PlanFit CheckUp process.
• Katie OHalloran, Interim CFO of GoHealth, stated that they expect various factors to influence the second half of the year and remain confident in their performance expectations for 2024.

Industry Context

The results reflect the challenges in the health insurance marketplace, particularly in the Medicare sector, where competition and changing consumer behavior impact submission volumes. GoHealth's focus on technology and AI aligns with industry trends towards digital transformation and personalized customer experiences.

Comparison to Industry Standards

• GoHealth's revenue decline contrasts with some competitors who have shown growth in the digital health space, such as eHealth, which has reported growth in certain segments.
• The decrease in submissions is a concern, as other companies in the insurance brokerage sector are focusing on increasing their agent networks and submission volumes.
• The negative Adjusted EBITDA is below the industry average for profitable companies in the health insurance marketplace, where many are aiming for positive EBITDA margins.
• GoHealth's investment in AI and automation is in line with industry trends, but the impact on cost reduction and efficiency needs to be demonstrated against competitors like SelectQuote, which also uses technology to drive sales.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and negative Adjusted EBITDA.
• Employees may be affected by the company's focus on efficiency and cost management.
• Customers may benefit from the company's investments in technology and personalized experiences.
• Suppliers and partners may be impacted by changes in the company's business strategy.

Next Steps

• GoHealth will intensify targeted marketing efforts for the upcoming Annual Enrollment Period (AEP).
• The company will continue to advance its technology, focusing on AI and automation.
• GoHealth will focus on agency versus non-agency agreements to drive cash flow performance.

Key Dates

Keywords

GoHealth, Medicare, health insurance, digital health, financial results, revenue, net loss, EBITDA, submissions, AI, automation, AEP, cash flow